1. Home
  2. LEGN vs GTES Comparison

LEGN vs GTES Comparison

Compare LEGN & GTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • GTES
  • Stock Information
  • Founded
  • LEGN 2014
  • GTES 1911
  • Country
  • LEGN United States
  • GTES United States
  • Employees
  • LEGN N/A
  • GTES N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • GTES Industrial Machinery/Components
  • Sector
  • LEGN Health Care
  • GTES Industrials
  • Exchange
  • LEGN Nasdaq
  • GTES Nasdaq
  • Market Cap
  • LEGN 6.7B
  • GTES 6.2B
  • IPO Year
  • LEGN 2020
  • GTES 2018
  • Fundamental
  • Price
  • LEGN $33.11
  • GTES $25.63
  • Analyst Decision
  • LEGN Strong Buy
  • GTES Buy
  • Analyst Count
  • LEGN 12
  • GTES 11
  • Target Price
  • LEGN $73.36
  • GTES $27.09
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • GTES 1.8M
  • Earning Date
  • LEGN 11-11-2025
  • GTES 10-29-2025
  • Dividend Yield
  • LEGN N/A
  • GTES N/A
  • EPS Growth
  • LEGN N/A
  • GTES N/A
  • EPS
  • LEGN N/A
  • GTES 0.78
  • Revenue
  • LEGN $796,838,000.00
  • GTES $3,391,400,000.00
  • Revenue This Year
  • LEGN $70.75
  • GTES $3.43
  • Revenue Next Year
  • LEGN $52.47
  • GTES $4.74
  • P/E Ratio
  • LEGN N/A
  • GTES $33.44
  • Revenue Growth
  • LEGN 74.75
  • GTES N/A
  • 52 Week Low
  • LEGN $27.34
  • GTES $14.70
  • 52 Week High
  • LEGN $52.31
  • GTES $26.42
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 36.16
  • GTES 54.66
  • Support Level
  • LEGN $33.20
  • GTES $25.10
  • Resistance Level
  • LEGN $34.71
  • GTES $26.42
  • Average True Range (ATR)
  • LEGN 1.22
  • GTES 0.57
  • MACD
  • LEGN -0.09
  • GTES -0.02
  • Stochastic Oscillator
  • LEGN 10.96
  • GTES 51.82

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About GTES Gates Industrial Corporation plc

Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.

Share on Social Networks: